메뉴 건너뛰기




Volumn 46, Issue 4, 2006, Pages 21-40

Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: The first twice-daily ophthalmic nonsteroidal anti-inflammatory drug

Author keywords

[No Author keywords available]

Indexed keywords

AMFENAC; BROMFENAC; BRONUCK; CORTICOSTEROID; CYCLOOXYGENASE 2; DICLOFENAC; INDOMETACIN; KETOROLAC; NEPAFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

EID: 33750345890     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iio.0000212134.83513.11     Document Type: Review
Times cited : (50)

References (54)
  • 1
    • 22744455811 scopus 로고    scopus 로고
    • Emerging guidelines for the use of NSAID therapy to optimize cataract surgery and patient care
    • O'Brien TP. Emerging guidelines for the use of NSAID therapy to optimize cataract surgery and patient care. Curr Med Res Opin. 2005;21:1131-1137.
    • (2005) Curr Med Res Opin , vol.21 , pp. 1131-1137
    • O'Brien, T.P.1
  • 2
    • 33044507658 scopus 로고    scopus 로고
    • Efficacy of topical Voltaren in reducing the incidence of postoperative cystoid macular edema
    • McColgin AZ, Raizman MB. Efficacy of topical Voltaren in reducing the incidence of postoperative cystoid macular edema. Invest Ophthalmol Vis Sci. 1999;40:S289.
    • (1999) Invest Ophthalmol Vis Sci , vol.40
    • McColgin, A.Z.1    Raizman, M.B.2
  • 3
    • 0033757470 scopus 로고    scopus 로고
    • Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema
    • Heier JS, Topping TM, Baumann W, et al. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmol. 2000;107:2034-2038.
    • (2000) Ophthalmol , vol.107 , pp. 2034-2038
    • Heier, J.S.1    Topping, T.M.2    Baumann, W.3
  • 4
    • 33750336217 scopus 로고    scopus 로고
    • Senju Pharmaceutical Company, Ltd, Osaka, Japan
    • Bronuck® package insert. Senju Pharmaceutical Company, Ltd, Osaka, Japan, 2003.
    • (2003) Bronuck® Package Insert
  • 7
    • 6344260351 scopus 로고    scopus 로고
    • Involvement of cyclooxygenase-2 in rat models of conjunctivitis
    • Oka T, Shearer TR, Azuma M. Involvement of cyclooxygenase-2 in rat models of conjunctivitis. Curr Eye Res. 2004;29:27-34.
    • (2004) Curr Eye Res , vol.29 , pp. 27-34
    • Oka, T.1    Shearer, T.R.2    Azuma, M.3
  • 8
    • 17544398602 scopus 로고    scopus 로고
    • Non-steroidal anti-inflammatory drugs and ocular inflammation
    • Guex-Crosier Y. Non-steroidal anti-inflammatory drugs and ocular inflammation. Klin Montasl Augenheilkd. 2001;218:305-308.
    • (2001) Klin Montasl Augenheilkd , vol.218 , pp. 305-308
    • Guex-Crosier, Y.1
  • 9
    • 0002953558 scopus 로고    scopus 로고
    • Lipid-derived autacoids: Eicosanoids and platelet-activating factor
    • Hardman JG, Limbird LE, Molinoff PB, et al, eds. New York, NY: McGraw-NeHill
    • Campbell WB, Halushka PV. Lipid-derived autacoids: eicosanoids and platelet-activating factor. In: Hardman JG, Limbird LE, Molinoff PB, et al, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-NeHill; 1996:601-616.
    • (1996) Goodman & Gilman's the Pharmacological Basis of Therapeutics. 9th Ed. , pp. 601-616
    • Campbell, W.B.1    Halushka, P.V.2
  • 10
    • 0021733791 scopus 로고
    • Anti-inflammatory agents. 3. Synthesis and pharmacological evaluation of 2-amino-3benzoylphenylacetic acid and analogues
    • Walsh DA, Moran HW, Shamblee DA, et al. Anti-inflammatory agents. 3. Synthesis and pharmacological evaluation of 2-amino-3benzoylphenylacetic acid and analogues. J Med Chem. 1984;11:1379-1388.
    • (1984) J Med Chem , vol.11 , pp. 1379-1388
    • Walsh, D.A.1    Moran, H.W.2    Shamblee, D.A.3
  • 11
    • 0027581690 scopus 로고
    • QSAR and conformational analysis of the anti-inflammatory agent amfenac and analogues
    • Ruiz J, Lopez M, Mila J, et al. QSAR and conformational analysis of the anti-inflammatory agent amfenac and analogues. J Comput-Aided Molec Design. 1993;7:183-198.
    • (1993) J Comput-Aided Molec Design , vol.7 , pp. 183-198
    • Ruiz, J.1    Lopez, M.2    Mila, J.3
  • 12
    • 0023230366 scopus 로고
    • The analgesic and antiinflammatory activity and pharmacologic properties of bromfenac
    • Sancilio LF, Nolan JC, Wagner LE, et al. The analgesic and antiinflammatory activity and pharmacologic properties of bromfenac. Arzneimittelforschung. 1987;37:513-519.
    • (1987) Arzneimittelforschung , vol.37 , pp. 513-519
    • Sancilio, L.F.1    Nolan, J.C.2    Wagner, L.E.3
  • 13
    • 0003979209 scopus 로고    scopus 로고
    • ISTA Pharmaceuticals, Inc.
    • Data on file. ISTA Pharmaceuticals, Inc.
    • Data on File
  • 14
    • 33750303458 scopus 로고
    • Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
    • Alcon Laboratories, Inc., assignee. U.S. Patent 5,475,034. December. 12
    • Yanni JM, Graff G, Hellberg MR. Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders. Alcon Laboratories, Inc., assignee. U.S. Patent 5,475,034. December. 12, 1995.
    • (1995)
    • Yanni, J.M.1    Graff, G.2    Hellberg, M.R.3
  • 15
    • 33745685717 scopus 로고    scopus 로고
    • Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium
    • Waterbury LD, Silliman D, Jolas T. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium. Curr Med Res Opin. 2006;22:1133-1140.
    • (2006) Curr Med Res Opin , vol.22 , pp. 1133-1140
    • Waterbury, L.D.1    Silliman, D.2    Jolas, T.3
  • 17
    • 48349101855 scopus 로고    scopus 로고
    • Use of non-steroidal anti-inflammatory agents in combination with compounds that have PF prostaglandin agonist activity to treat glaucoma and ocular hypertension
    • Alcon Laboratories, Inc., assignee. U.S. Patent 6,342,524 B1. January. 29
    • Helberg MR, Nixon JC. Use of non-steroidal anti-inflammatory agents in combination with compounds that have PF prostaglandin agonist activity to treat glaucoma and ocular hypertension. Alcon Laboratories, Inc., assignee. U.S. Patent 6,342,524 B1. January. 29, 2002.
    • (2002)
    • Helberg, M.R.1    Nixon, J.C.2
  • 20
    • 33750332012 scopus 로고    scopus 로고
    • Effect of bromfenac sodium ophthalmic solution on inflammation following intraocular lens implantation
    • Masuda K, Fukado Y, Shimizu H, et al. Effect of bromfenac sodium ophthalmic solution on inflammation following intraocular lens implantation. Ganka Rinsho Iho (Jpn Rev Clin Ophthalmol). 1997;91:745-750.
    • (1997) Ganka Rinsho Iho (Jpn Rev Clin Ophthalmol) , vol.91 , pp. 745-750
    • Masuda, K.1    Fukado, Y.2    Shimizu, H.3
  • 21
    • 0037594952 scopus 로고    scopus 로고
    • Effect of bromfenac ophthalmic solution on ocular inflammation and corneal epithelial barrier function following cataract surgery
    • Kawaguchi T, Kida T, Nemoto S, et al. Effect of bromfenac ophthalmic solution on ocular inflammation and corneal epithelial barrier function following cataract surgery. Folia Ophthalmol Jpn. 2003;54:276-279.
    • (2003) Folia Ophthalmol Jpn , vol.54 , pp. 276-279
    • Kawaguchi, T.1    Kida, T.2    Nemoto, S.3
  • 22
    • 0042031376 scopus 로고    scopus 로고
    • Efficacy and adverse effects of bromfenac ophthalmic solution following cataract surgery
    • Takamatsu F, Shiroyama N, Saito Y, et al. Efficacy and adverse effects of bromfenac ophthalmic solution following cataract surgery. Rinsho Ganka (Jpn J Clin Ophthalmol). 2003;57:1233-1237.
    • (2003) Rinsho Ganka (Jpn J Clin Ophthalmol) , vol.57 , pp. 1233-1237
    • Takamatsu, F.1    Shiroyama, N.2    Saito, Y.3
  • 23
    • 33750375109 scopus 로고    scopus 로고
    • Effect of bromfenac sodium on postoperative inflammation
    • Ohara K, Ohkuba A, Miyamoto T, et al. Effect of bromfenac sodium on postoperative inflammation. Jpn J Catarac Refract Surg. 2004;18:1-12.
    • (2004) Jpn J Catarac Refract Surg , vol.18 , pp. 1-12
    • Ohara, K.1    Ohkuba, A.2    Miyamoto, T.3
  • 24
    • 33750333043 scopus 로고    scopus 로고
    • Integrated results from two phase III studies of topical Xibrom™ 0.1%, an investigational NSAID for post-cataract surgery inflammation
    • New Orleans, LA, October 24
    • Stewart RH, Walters TR, Cooke DL, et al. Integrated results from two phase III studies of topical Xibrom™ 0.1%, an investigational NSAID for post-cataract surgery inflammation. Proceedings of the 108th Annual American Academy of Ophthalmology Meeting, New Orleans, LA, October 24, 2004.
    • (2004) Proceedings of the 108th Annual American Academy of Ophthalmology Meeting
    • Stewart, R.H.1    Walters, T.R.2    Cooke, D.L.3
  • 26
    • 33750292433 scopus 로고    scopus 로고
    • Topical Xibrom™ 0.09% significantly and rapidly decreased post-cataract surgery inflammation and reduced ocular pain
    • (E-abstract 791)
    • Donnenfeld ED, Holland EJ, Stewart RH, et al. Topical Xibrom™ 0.09% significantly and rapidly decreased post-cataract surgery inflammation and reduced ocular pain (E-abstract 791). Invest Ophthalmol Vis Sci. 2005;46.
    • (2005) Invest Ophthalmol Vis Sci , pp. 46
    • Donnenfeld, E.D.1    Holland, E.J.2    Stewart, R.H.3
  • 28
    • 0002734554 scopus 로고
    • Nonsteroidal anti-inflammatory drugs
    • Tasman W, ed. Philadelphia: Lippincott
    • Flach AJ. Nonsteroidal anti-inflammatory drugs. In: Tasman W, ed. Duane's Foundations in Clinical Ophthalmology. Philadelphia: Lippincott; 1994:1-32.
    • (1994) Duane's Foundations in Clinical Ophthalmology , pp. 1-32
    • Flach, A.J.1
  • 29
    • 3242772245 scopus 로고    scopus 로고
    • Prevention of miosis during cataract surgery by topical bromfenac sodium
    • Ohara K, Ohkubo A, Miyamoto T, et al. Prevention of miosis during cataract surgery by topical bromfenac sodium. Rinsho Ganka (Jpn J Clin Ophthalmol). 2004;58:1325-1328.
    • (2004) Rinsho Ganka (Jpn J Clin Ophthalmol) , vol.58 , pp. 1325-1328
    • Ohara, K.1    Ohkubo, A.2    Miyamoto, T.3
  • 30
    • 12144264233 scopus 로고    scopus 로고
    • Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis
    • Miyake-Kashima M, Takano Y, Tanaka M, et al. Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis. Jpn J Ophthalmol. 2004;48:587-590.
    • (2004) Jpn J Ophthalmol , vol.48 , pp. 587-590
    • Miyake-Kashima, M.1    Takano, Y.2    Tanaka, M.3
  • 31
    • 33750289768 scopus 로고    scopus 로고
    • Effect of bromfenac sodium (AHR-10282B) eye drops on anterior uveitis
    • Usui M, Masuda K. Effect of bromfenac sodium (AHR-10282B) eye drops on anterior uveitis. Ganka Rinsho Iho (J Rev Clin Ophthalmol). 1997;91:39-44.
    • (1997) Ganka Rinsho Iho (J Rev Clin Ophthalmol) , vol.91 , pp. 39-44
    • Usui, M.1    Masuda, K.2
  • 32
    • 0346098252 scopus 로고    scopus 로고
    • Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac
    • Rho DS. Treatment of acute pseudophakic cystoid macular edema: diclofenac versus ketorolac. J Cataract Refract Surg. 2003;29:2378-2384.
    • (2003) J Cataract Refract Surg , vol.29 , pp. 2378-2384
    • Rho, D.S.1
  • 33
    • 85121054141 scopus 로고    scopus 로고
    • Bromfenac 0.09% versus diclofenac sodium 0.1% versus ketorolac tromethamine 0.5% in the treatment of acute pseudophakic cystoid macular edema
    • Ft. Lauderdale, FL, April 30-May 4
    • Rho DS, Soll SM, Markovitz BJ. Bromfenac 0.09% versus diclofenac sodium 0.1% versus ketorolac tromethamine 0.5% in the treatment of acute pseudophakic cystoid macular edema. Proceedings of the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Ft. Lauderdale, FL, April 30-May 4, 2006. A5211.
    • (2006) Proceedings of the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
    • Rho, D.S.1    Soll, S.M.2    Markovitz, B.J.3
  • 34
    • 33750289015 scopus 로고    scopus 로고
    • A prospective randomized comparison of bromfenac with ketorolac for the treatment of patients with reduced visual acuity following glaucoma surgery
    • Charleston, SC, March 2-5
    • Solish, AM. A prospective randomized comparison of bromfenac with ketorolac for the treatment of patients with reduced visual acuity following glaucoma surgery. Proceedings of the 16th Annual American Glaucoma Society (AGS) Meeting, Charleston, SC, March 2-5, 2006.
    • (2006) Proceedings of the 16th Annual American Glaucoma Society (AGS) Meeting
    • Solish, A.M.1
  • 35
    • 0035029473 scopus 로고    scopus 로고
    • Keratitis, ulceration, and perforation associated with topical non-steroidal anti-inflammatory drugs
    • Guidera AC, Luchs JI, Udell IJ. Keratitis, ulceration, and perforation associated with topical non-steroidal anti-inflammatory drugs. Ophthalmol. 2001;108:936-944.
    • (2001) Ophthalmol , vol.108 , pp. 936-944
    • Guidera, A.C.1    Luchs, J.I.2    Udell, I.J.3
  • 36
    • 0035320753 scopus 로고    scopus 로고
    • Corneal complications associated with topical ophthalmic use of nonsteroidal anti-inflammatory drugs
    • Congdon NG, Schein OD, von Kulata P, et al. Corneal complications associated with topical ophthalmic use of nonsteroidal anti-inflammatory drugs. J Cataract Refract Surg. 2001;27:622-631.
    • (2001) J Cataract Refract Surg , vol.27 , pp. 622-631
    • Congdon, N.G.1    Schein, O.D.2    Von Kulata, P.3
  • 37
    • 0035696994 scopus 로고    scopus 로고
    • Ketorolac in the era of cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drugs: A systematic review of efficacy, side effects, and regulatory issues
    • Macario A, Lipman AG. Ketorolac in the era of cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drugs: a systematic review of efficacy, side effects, and regulatory issues. Pain Med. 2001;2:336-351.
    • (2001) Pain Med , vol.2 , pp. 336-351
    • Macario, A.1    Lipman, A.G.2
  • 38
    • 33750373190 scopus 로고    scopus 로고
    • Clinical effect of bromfenac sodium ophthalmic solution on inflammation following intraocular lens implantation: Optimal frequency of instillation
    • Shimizu H, Matsuda K, Fukado Y, et al. Clinical effect of bromfenac sodium ophthalmic solution on inflammation following intraocular lens implantation: optimal frequency of instillation. Atarashii Ganka. 1997;14:309-316.
    • (1997) Atarashii Ganka , vol.14 , pp. 309-316
    • Shimizu, H.1    Matsuda, K.2    Fukado, Y.3
  • 39
    • 0030908278 scopus 로고    scopus 로고
    • Effect of bromfenac sodium on post-operative inflammation - A double-masked trial
    • Masuda K, Fukado Y, Shimizu H, et al. Effect of bromfenac sodium on post-operative inflammation - a double-masked trial. Folia Ophthalmol Japan. 1997;48:560-569.
    • (1997) Folia Ophthalmol Japan , vol.48 , pp. 560-569
    • Masuda, K.1    Fukado, Y.2    Shimizu, H.3
  • 40
    • 0030844272 scopus 로고    scopus 로고
    • Efficacy of bromfenac sodium ophthalmic solution for ocular surface inflammation - A double-masked controlled trial
    • Sawa M, Masuda K, Usui M, et al. Efficacy of bromfenac sodium ophthalmic solution for ocular surface inflammation - a double-masked controlled trial. Folia Ophthalmol Jpn. 1997;48:717-724.
    • (1997) Folia Ophthalmol Jpn , vol.48 , pp. 717-724
    • Sawa, M.1    Masuda, K.2    Usui, M.3
  • 41
    • 0003979209 scopus 로고    scopus 로고
    • ISTA Pharmaceuticals, Inc.
    • Data on file. ISTA Pharmaceuticals, Inc.
    • Data on File
  • 42
    • 0003979209 scopus 로고    scopus 로고
    • ISTA Pharmaceuticals, Inc.
    • Data on file. ISTA Pharmaceuticals, Inc.
    • Data on File
  • 43
    • 0003979209 scopus 로고    scopus 로고
    • ISTA Pharmaceuticals, Inc.
    • Data on file. ISTA Pharmaceuticals, Inc.
    • Data on File
  • 44
    • 33750312736 scopus 로고    scopus 로고
    • Post-marketing surveillance of bromfenac sodium (Bronuck®) ophthalmic solution
    • Kitao N, Shimoji H, Fukuda M. Post-marketing surveillance of bromfenac sodium (Bronuck®) ophthalmic solution. Atarashii Ganka (J of the Eye). 2005;22:1299-1308.
    • (2005) Atarashii Ganka (J of the Eye) , vol.22 , pp. 1299-1308
    • Kitao, N.1    Shimoji, H.2    Fukuda, M.3
  • 45
    • 0038459329 scopus 로고    scopus 로고
    • Two cases of corneal ulcer following instillation of bromfenac sodium ophthalmic solution
    • Mochizuki M, Nakagami T, Asai T. Two cases of corneal ulcer following instillation of bromfenac sodium ophthalmic solution. Rinsho Ganka (Jpn J Clin Ophthalmol). 2003;57:675-679.
    • (2003) Rinsho Ganka (Jpn J Clin Ophthalmol) , vol.57 , pp. 675-679
    • Mochizuki, M.1    Nakagami, T.2    Asai, T.3
  • 46
    • 33644839861 scopus 로고    scopus 로고
    • Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug
    • Asai T, Nakagami T, Mochizuki M, et al. Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug. Cornea. 2006;25:224-227.
    • (2006) Cornea , vol.25 , pp. 224-227
    • Asai, T.1    Nakagami, T.2    Mochizuki, M.3
  • 47
    • 0003979209 scopus 로고    scopus 로고
    • ISTA Pharmaceuticals, Inc.
    • Data on file. ISTA Pharmaceuticals, Inc.
    • Data on File
  • 49
    • 0034760617 scopus 로고    scopus 로고
    • Evaluation and multivariate statistical analysis of factors influencing patient adherence to ophthalmic solutions
    • Ikeda H, Sato M, Tsukamoto H, et al. Evaluation and multivariate statistical analysis of factors influencing patient adherence to ophthalmic solutions. Yakugaku Zasshi. 2001;121:799-806.
    • (2001) Yakugaku Zasshi , vol.121 , pp. 799-806
    • Ikeda, H.1    Sato, M.2    Tsukamoto, H.3
  • 50
    • 0003979209 scopus 로고    scopus 로고
    • ISTA Pharmaceuticals, Inc.
    • Data on file. ISTA Pharmaceuticals, Inc.
    • Data on File
  • 51
    • 0003979209 scopus 로고    scopus 로고
    • ISTA Pharmaceuticals, Inc.
    • Data on file. ISTA Pharmaceuticals, Inc.
    • Data on File
  • 53
    • 0036303314 scopus 로고    scopus 로고
    • Effect of topical diclofenac and ketorolac on patient discomfort and corneal sensitivity
    • Narvaez J, Kroll P, Guzek JP. Effect of topical diclofenac and ketorolac on patient discomfort and corneal sensitivity. J Refract Surgery. 2002;18:145-148.
    • (2002) J Refract Surgery , vol.18 , pp. 145-148
    • Narvaez, J.1    Kroll, P.2    Guzek, J.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.